关注
Valerie Sabatier
Valerie Sabatier
在 grenoble-em.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
From recipe to dinner: business model portfolios in the European biopharmaceutical industry
V Sabatier, V Mangematin, T Rousselle
Long Range Planning 43 (2-3), 431-447, 2010
4542010
When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry
V Sabatier, A Craig-Kennard, V Mangematin
Technological Forecasting and Social Change 79 (5), 949-962, 2012
2802012
Learning, signaling, and convincing: The role of experimentation in the business modeling process
N Bojovic, C Genet, V Sabatier
Long Range Planning 51 (1), 141-157, 2018
902018
Articulating growth and cultural innovation in art museums: The Louvre's business model revision
E Coblence, V Sabatier
International Studies of Management & Organization 44 (4), 9-25, 2014
622014
Becoming through doing: How experimental spaces enable organizational identity work
N Bojovic, V Sabatier, E Coblence
Strategic Organization 18 (1), 20-49, 2020
502020
Social business model design and implementation in developing countries: Learning from an affordable medicine developed in Burkina Faso
V Sabatier, I Medah, P Augsdorfer, A Maduekwe
Journal of Management Development 36 (1), 48-57, 2017
502017
Orchestrating networks in the biopharmaceutical industry: small hub firms can do it
V Sabatier, V Mangematin, T Rousselle
Production Planning and Control 21 (2), 218-228, 2010
442010
Strategic renewal in times of environmental scarcity: The mediating role of technology in business model evolution
S Al Humaidan, V Sabatier
Journal of Organizational Change Management 30 (1), 106-120, 2017
352017
The role of costs in business model design for early-stage technology startups
RG Chammassian, V Sabatier
Technological Forecasting and Social Change 157, 120090, 2020
342020
Psychological, social and technical factors influencing electronic medical records systems adoption by United States physicians: a systematic model
R El-Yafouri, L Klieb, V Sabatier
Health Research Policy and Systems 20 (1), 48, 2022
132022
Rethinking business models for innovation
V Chanal, S Akselsen, S Blanco, ML Caron-Fasan, B Cartoux, ...
Rethinking business models for innovation, 154, 2011
112011
What innovative business models can be triggered by precision medicine? Analogical reasoning from the magazine industry
N Bojovic, V Sabatier, S Rouault
Innovation and Entrepreneurship in Health, 81-94, 2015
82015
Discontinuités téchnologiques et business models: analyse des mécanismes de transformation de l'industrie du médicament
V Sabatier
Université de Grenoble, 2011
62011
From business model to business model portfolio in the European biopharmaceutical industry
V Sabatier, V Mangematin, T Rouselle
HAL Working Papers, 2009
52009
The impact of office-related metrics on meeting physician expectations from Electronic Medical Record systems
R El-Yafouri, L Klieb, V Sabatier
Healthcare Analytics 4, 100208, 2023
42023
Going virtual in the European Biopharmaceutical Industry: Conductors and Oxpeckers make it
V Sabatier, V Mangematin, T Rousselle
Working Conference on Virtual Enterprises, 93-104, 2008
12008
Psychological, Social and Technical Factors Influencing Electronic Medical Records Systems Adoption by US Physicians: A Systematic Model
R El-Yafouri, L Klieb, V Sabatier
2020
How does one encourage the production of vaccines in Developing Countries?
S Meniri, P Legeard, V Sabatier
2013
How to encourage the production of vaccines for developing countries?
S Meniri, P Legeard, V Sabatier
BIOFUTUR, 54-57, 2013
2013
Innovation Buy-In at Schneider Electric: The KIBIS Method
S Blanco, V Sabatier, C Genet, B Cartoux
Discontinuous Innovation: Learning To Manage The Unexpected 22, 289, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–20